who owns the patent for retatrutide News: Lilly is fighting FDA in court in an attempt to have the triple agonist peptide classified as a biologic. We broke down the potential strategy of Lilly on today’s podcast. There Is No Real Retatrutide.

Working with knowledgeable practitioners who can adjust protocols based on individual response makes the difference between struggling through treatment and thriving on it

If youre taking diabetes medications, please discuss this with your prescribing doctor before starting a GLP-1, as your diabetes medications may need to be adjusted as you lose weight

The byproduct of oxidation is the creation of free radicals which are unstable molecules

According to the ASDS, photodynamic treatment is quite efficient for treating inflammatory acne vulgaris, precancerous lesions, and superficial nonmelanoma skin malignancies [147]